Safety Information
| Description | Publish Date | LINKS |
|---|---|---|
| Important safety information on Dolutegravir in Botswana |
10/10/2018 |
 |
| Important safety information on Abacavir: Hypersensitivity reaction - educational slide deck | 15/02/2024 | |
Important safety information on Abacavir containing products - Regarding amendments to the instructions for medical use of medicines containing abacavir |
19/03/2024 | |
| Important safety information on Cefuroxime axetil suspension in Botswana: Notification about recall | 28/09/2021 | |
| Important safety information on Cephalosporins in Botswana (Safety Notification_Cephalosporins and risk of seizure) | 01/03/2023 | |
Important safety information on Cephalosporins in Botswana (Safety Notification_Cephalosporins and risk of neurotoxicity) |
07/03/2023 |
|
Important safety information on Amoxicillin / Amoxicillin and clavulanic acid containing products in Botswana |
09/09/2023 | |
Important safety information on Amoxicillin/clavulanic acid containing products - MedSafe communication regarding labelling updates |
19/12/2023 | |
| Important safety information on Dolutegravir containing products in Botswana (Safety Notification_Korean label update for Dolutegravir containing products) | 02-11-2023 | |
Important safety information on Paroxetine containing products - Modifications of the information of medicines authorized by national procedure that contain Paroxetine |
27/12/2023 | |
